Inactive Instrument

Exactus Inc Share Price OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	5L 5L 4L 4L 7L 4.97Cr 8L 50.52L 19.63L 2.43Cr 19.49L 19.06L 8.44Cr	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	2.2Cr 1.93Cr 1.79Cr 1.65Cr 3.13Cr 211.12Cr 3.19Cr 21Cr 8.34Cr 103.31Cr 8.28Cr 8.1Cr 358.64Cr	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/23/05	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/23/30	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

18/11	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/24/16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/24/16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/23/05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/23/02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-1.60%	+1.37%	+57.31%	+168.94%	1,10200Cr
JOHNSON & JOHNSON	-1.44%	+3.71%	+69.64%	+65.40%	64TCr
ABBVIE INC.	-0.75%	+0.44%	+34.70%	+86.52%	45TCr
ROCHE HOLDING AG	-1.35%	+0.63%	+30.26%	+26.28%	34TCr
ASTRAZENECA PLC	-0.86%	+0.99%	+39.36%	+40.85%	30TCr
NOVARTIS AG	-0.71%	-0.54%	+28.98%	+48.27%	29TCr
NOVO NORDISK A/S	-1.31%	+2.72%	-26.76%	-39.82%	22TCr
AMGEN INC.	-0.03%	+1.84%	+23.90%	+63.75%	20TCr
GILEAD SCIENCES, INC.	-0.40%	+7.82%	+22.29%	+79.44%	17TCr
Average	-0.95%	+2.47%	+31.08%	+59.96%	41.18TCr
Weighted average by Cap.	-1.13%	+2.14%	+42.20%	+86.16%

	2022	2023
Net sales	16.27L 14.27L 13.17L 12.17L 23.08L 16Cr 23.54L 1.58Cr 61.54L 7.62Cr 61.1L 59.76L 26Cr	23.85L 20.92L 19.31L 17.85L 33.83L 23Cr 34.5L 2.32Cr 90.21L 11Cr 89.56L 87.6L 39Cr
Net income	-91.43L -80.19L -74.03L -68.41L -1.3Cr -88Cr -1.32Cr -8.9Cr -3.46Cr -43Cr -3.43Cr -3.36Cr -148.71Cr	-80.15L -70.3L -64.9L -59.98L -1.14Cr -77Cr -1.16Cr -7.8Cr -3.03Cr -38Cr -3.01Cr -2.94Cr -130.38Cr
Net Debt	1.79Cr 1.57Cr 1.45Cr 1.34Cr 2.53Cr 170.95Cr 2.58Cr 17Cr 6.75Cr 84Cr 6.7Cr 6.56Cr 290.41Cr	2.15Cr 1.89Cr 1.74Cr 1.61Cr 3.05Cr 206.15Cr 3.11Cr 21Cr 8.14Cr 100.88Cr 8.08Cr 7.91Cr 350.2Cr

Exactus Inc Share Price OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile